Salbutamol Completed Phase 1 Trials for Pompe's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01859624Albuterol in Individuals With Late Onset Pompe Disease (LOPD)